Explore the vast range of titles available.

Extremely low frequency magnetic fields (ELF-MF) could be an alternative neuroprotective approach for ischemic stroke because preclinical studies have demonstrated their effects on the mechanisms underlying ischemic damage. The purpose of this open-label, one arm, dose-escalation, exploratory study is to evaluate the safety and tolerability of ELF-MF in patients with acute ischemic stroke. Within 48 hours from the stroke onset, patients started ELF-MF treatment, daily for 5 consecutive days. Clinical follow-up lasted 12 months. Brain MRI was performed before and 1 month after the treatment. The distribution of ELF-MF in the ischemic lesion was estimated by dosimetry. Six patients were stimulated, three for 45 min/day and three for 120 min/day. None of them reported adverse events. Clinical conditions improved in all the patients. Lesion size was reduced in one patient stimulated for 45 minutes and in all the patients stimulated for 120 minutes. Magnetic field intensity within the ischemic lesion was above 1 mT, the minimum value able to trigger a biological effect in preclinical studies. Our pilot study demonstrates that ELF-MF are safe and tolerable in acute stroke patients. A prospective, randomized, placebo-controlled, double-blind study will clarify whether ELF-MFs could represent a potential therapeutic approach.

Background Osteoporosis (OP) and osteoarthritis (OA) are prevalent skeletal disorders among postmenopausal women. Coexistence is common especially that of postmenopausal osteoporosis (PMO) and lumbar OA. An hypothesis has been raised that OP and OA might share the same pathogenic mechanism, and pulsed electromagnetic fields (PEMFs) were reported to have anti-osteoporosis and anti-osteoarthritis properties, but this suggestion was based primarily on biomarker data. Therefore, whether these two effects could take place simultaneously has not yet been investigated. This randomized controlled trial (RCT) is designed to explore the effect of PEMFs for PMO and concomitant lumbar OA. Methods/Design The study will include PMO patients (postmenopausal women; aged between 50 and 70 years; have been postmenopausal for at least 5 years and diagnosed with OP using proximal femur T-score) with concomitant lumbar OA (patients with confounding disorders like diabetes, hypertension, hyperlipidemia, and previous fracture history, etcetera , will be excluded) will be randomly assigned to two arms: PEMFs group and sham PEMFs group. There will be 25 participants in each arm (50 in total) and the outcome assessment, including the primary endpoint (proximal femur bone mineral density), will be performed at 5 weeks, 3 months and 6 months after enrollment. Discussion PMO and lumbar OA are prominent public health problem, especially for postmenopausal women. We hope this RCT will provide scientific evidence to primary care of the postmenopausal women regarding the use of these nonpharmaceutical, noninvasive modalities, PEMFs, in managing PMO and lumbar OA. Trial registration Chinese Clinical Trial Registry: ChiCTR-TRC-14005156 (28 August 2014).

Exposure to man-made electromagnetic fields (EMFs), which increasingly pollute our environment, have consequences for human health about which there is continuing ignorance and debate. Whereas there is considerable ongoing concern about their harmful effects, magnetic fields are at the same time being applied as therapeutic tools in regenerative medicine, oncology, orthopedics, and neurology. This paradox cannot be resolved until the cellular mechanisms underlying such effects are identified. Here, we show by biochemical and imaging experiments that exposure of mammalian cells to weak pulsed electromagnetic fields (PEMFs) stimulates rapid accumulation of reactive oxygen species (ROS), a potentially toxic metabolite with multiple roles in stress response and cellular ageing. Following exposure to PEMF, cell growth is slowed, and ROS-responsive genes are induced. These effects require the presence of cryptochrome, a putative magnetosensor that synthesizes ROS. We conclude that modulation of intracellular ROS via cryptochromes represents a general response to weak EMFs, which can account for either therapeutic or pathological effects depending on exposure. Clinically, our findings provide a rationale to optimize low field magnetic stimulation for novel therapeutic applications while warning against the possibility of harmful synergistic effects with environmental agents that further increase intracellular ROS.

•First investigation of 5 G RF-EMF effects on NREM sleep spindles in genetic context.•Variant rs7304986 of CACNA1C modulates 5 G effects on spindle center frequency.•Exposure to 3.6 GHz 5 G RF-EMF accelerates spindle frequency in T/C allele carriers.•Spindle frequency in T/C carriers accelerated over widespread cortical areas.•Studies elucidating biological mechanisms underlying 5 G RF-EMF effects warranted. The introduction of 5G technology as the latest standard in mobile telecommunications has raised concerns about its potential health effects. Prior studies of earlier generations of radiofrequency electromagnetic fields (RF-EMF) demonstrated narrowband spectral increases in the electroencephalographic (EEG) spindle frequency range (11–16 Hz) in non-rapid-eye-movement (NREM) sleep. However, the impact of 5G RF-EMF on sleep remains unexplored. Additionally, RF-EMF can activate l-type voltage-gated calcium channels (LTCC), which have been linked to sleep quality and EEG oscillatory activity. This study investigates whether the allelic variant rs7304986 in the CACNA1C gene, encoding the α1C subunit of LTCC, modulates 5G RF-EMF effects on EEG spindle activity in NREM sleep. Thirty-four participants, genotyped for rs7304986 (15 T/C and 19 matched T/T carriers), underwent a double-blind, sham-controlled study with standardized left-hemisphere exposure to two 5G RF-EMF signals (3.6 GHz and 700 MHz) for 30 min before sleep. Sleep spindle activity was analyzed using high-density EEG and the Fitting Oscillations & One Over f (FOOOF) algorithm. T/C carriers reported longer sleep latency compared to T/T carriers. A significant interaction between RF-EMF exposure and rs7304986 genotype was observed, with only 3.6 GHz exposure in T/C carriers inducing a faster spindle center frequency in the central, parietal, and occipital cortex compared to sham. These findings suggest that 3.6 GHz 5G RF-EMF modulates spindle center frequency in NREM sleep in a CACNA1C genotype-dependent manner, implicating LTCC in the physiological response to RF-EMF and underscoring the need for further research into 5G effects on brain health.

ObjectivesStudies assessing the association of adult cancers with extremely low frequency (ELF) magnetic fields (MF) have provided inconclusive results, probably affected by limitations such as low exposure levels, confounding and various forms of bias. This study investigated the association between residential ELF MF exposure and adult cancer using a design that avoids the main limitations of previous studies.MethodsPersons who have lived in buildings with indoor transformer stations during the period 1971–2016 formed the study cohort. Their MF exposure was assessed based on the location of their apartment in relation to the transformer room. Information on their cancer diagnoses was obtained from the Finnish Cancer Registry. SIR with 95% CI was calculated to investigate the association of MF exposure with overall cancer and specific cancers.ResultsThe SIR for all primary sites was 1.01 (95% CI 0.93 to 1.09). An increased risk of digestive organ cancers was observed among the exposed persons, with a SIR of 1.23 (95% CI 1.03 to 1.46). The highest SIR was observed for gallbladder cancer (3.92, 95% CI 1.44 to 8.69). Increased risk of testicular cancer was observed among men exposed to MF during childhood, but this is likely to be due to confounding associated with living on the lowest floors. No other significant associations were observed for other primary cancer sites studied.ConclusionsOverall cancer risk was not affected by residential MF exposure. The increased risk of digestive organ cancers among MF-exposed persons is a novel finding requiring confirmation in further studies.

Electromagnetic fields emitted from overhead power lines and subsea cables are widely regarded to be a disruptive factor for animals using the natural magnetic field as orientation cue for guiding their directed movements. However, it is not known if anthropogenic electromagnetic fields also have the potential to disturb animals attending to information from other sensory modalities. To find out, we trained adult zebrafish ( Danio rerio ) individually to perform avoidance behavior in response to a visual signal (green LED light spot), which in the exposure group was presented simultaneously with a sinusoidally changing magnetic field (0.3 Hz, group A: 0.015 mT, group B: 0.06 mT). Despite the salience of the visual signal, which was both sufficient and necessary to elicit conditioned avoidance responses, the 0.06 mT magnetic condition had a negative impact on learning performance and response behavior. This suggests that extremely low frequency technical magnetic fields of Earth strength amplitude can act as cross-modal distractor that diverts the attention of animals away from environmentally relevant cues based on nonmagnetic sensory modalities. Our research highlights the need to study the role of anthropogenic magnetic fields as sensory pollutant beyond the scope of magnetic orientation behavior.

The interaction between biological tissue and electromagnetic fields (EMF) is a topic of increasing interest due to the rising prevalence of background EMF in the past decades. Previous studies have attempted to measure the effects of EMF on brainwaves using EEG recordings, but are typically hampered by experimental and environmental factors. In this study, we present a framework for measuring the impact of EMF on EEG while controlling for these factors. A Bayesian statistical approach is employed to provide robust statistical evidence of the observed EMF effects. This study included 32 healthy participants in a double-blinded crossover counterbalanced design. EEG recordings were taken from 63 electrodes across 6 brain regions. Participants underwent a measurement protocol comprising two 18-min sessions with alternating blocks of eyes open (EO) and eyes closed (EC) conditions. Group 1 (n = 16) had EMF during the first session and sham during the second session; group 2 (n = 16) had the opposite. Power spectral density plots were generated for all sessions and brain regions. The Bayesian analysis provided statistical evidence for the presence of an EMF effect in the alpha band power density in the EO condition. This measurement protocol holds potential for future research on the impact of novel transmission protocols.

Arterial ischaemic stroke (AIS) can cause disabling hemiparesis in children. We aimed to test whether contralesional, inhibitory repetitive transcranial magnetic stimulation (rTMS) could affect interhemispheric inhibition to improve hand function in chronic subcortical paediatric AIS. Patients were eligible for this parallel, randomised trial if they were in the SickKids Children's Stroke Program and had subcortical AIS more than 2 years previously, had transcallosal sparing, were more than 7 years of age, had hand motor impairment, had no seizures or dyskinesia, and were taking no drugs that alter cortical excitability. Patients were paired for age and weakness and were randomised within each pair to sham treatment or inhibitory, low-frequency rTMS over contralesional motor cortex (20 min, 1200 stimuli) once per day for 8 days. An occupational therapist did standardised tests of hand function at days 1 (baseline), 5, 10, and 17 (1 week post-treatment), and the primary outcomes were changes in grip strength and the Melbourne assessment of upper extremity function (MAUEF) between baseline and day 10. Patients, parents, and occupational therapists were blinded to treatment allocation. Analysis was per protocol. Ten patients with paediatric stroke were enrolled (median age 13·25 [IQR 10·08–16·78] years, mean time post-stroke 6·33 [SD 3·56] years): four with mild weakness, two with moderate weakness, and four with severe weakness. A repeated-measures ANOVA showed a significant interaction between time and the effect of treatment on grip strength (p=0·03). At day 10, grip strength was 2·28 (SD 1·01) kg greater than baseline in the rTMS group and 2·92 (1·20) kg less than baseline in the sham group (p=0·009). Benefits in mean grip strength persisted at day 17 (2·63 [0·56] kg greater than baseline with rTMS and 1·00 [0·70] kg less than baseline with sham treatment; p=0·01). Day 10 MAUEF score improved by more in the rTMS group than in the sham group (7·25 [3·8] vs 0·79 [1·3] points greater than baseline; p=0·002), but this benefit did not persist to day 17. Function of the unaffected hand remained stable. rTMS was well tolerated with no serious adverse events. Contralesional inhibitory rTMS was safe and feasible for patients with paediatric subcortical AIS, and seemed to improve hand function in patients with hemiparesis. Further studies are required to confirm the potential role of rTMS in paediatric neurorehabilitation. Canadian Stroke Consortium; Canadian Institutes of Health Research; American Academy of Neurology Foundation; Alberta Heritage Foundation for Medical Research.

Although mobile phone (MP) use has been steadily increasing in the last decades and similar positive trends are expected for the near future, systematic investigations on neurophysiological and cognitive effects caused by recently developed technological standards for MPs are scarcely available. Here, we investigated the effects of radiofrequency (RF) fields emitted by new-generation mobile technologies, specifically, Universal Mobile Telecommunications System (UMTS) and Long-Term Evolution (LTE), on intrinsic scalp EEG activity in the alpha band (8–12 Hz) and cognitive performance in the Stroop test. The study involved 60 healthy, young-adult university students (34 for UMTS and 26 for LTE) with double-blind administration of Real and Sham exposure in separate sessions. EEG was recorded before, during and after RF exposure, and Stroop performance was assessed before and after EEG recording. Both RF exposure types caused a notable decrease in the alpha power over the whole scalp that persisted even after the cessation of the exposure, whereas no effects were found on any aspects of performance in the Stroop test. The results imply that the brain networks underlying global alpha oscillations might require minor reconfiguration to adapt to the local biophysical changes caused by focal RF exposure mimicking MP use.

ABSTRACT The objective of this study was to establish guidelines for evaluating the health effects of electromagnetic fields (EMFs). To achieve this, a comprehensive evaluation of EMF effects on living organisms from both engineering and biological perspectives is essential. As part of this study, we examined the impact of intermediate-frequency magnetic fields (IF-MF) exposure on peripheral nerves in mice and validated the reliability of five pain assessment methods. The engineering approach was based on our pilot study, while the biological approach involved exposing mice to IF-MF for a 28-day period and assessing neurotoxicity through the implementation of five pain tests. The von Frey test, conducted with a Dynamic Plantar Aesthesiometer, was performed at various time points during exposure. The results indicated that leg withdrawal time was shortened only in the positive control group. After conducting a series of assessments, we demonstrated that no statistically significant differences were observed among the IF-MF-exposed, sham-exposed and control groups. However, the positive control group exhibited significant variations in the four supplemental assessments. No significant differences were detected in the other three groups. These findings suggest that subacute (28-day) IF-MF exposure at 2.3 times the basic restriction for occupational exposure according to International Commission on Non-Ionizing Radiation Protection guideline does not result in peripheral neurotoxicity and that the utilized pain assessment methods used for IF-MF exposure are effective.